Cargando…

Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor

The urotensin receptor (UT receptor), a G-protein-coupled receptor mediating urotensin-II and urotensin-II-related peptide signaling in the urotensinergic system, has multiple pharmacological activities. However, there is no drug targeting the UT receptor currently in clinical use, and the discovery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Na, Yin, Lin, Chen, Xi, Shang, Jiamin, Liang, Meidai, Gao, Li, Qiang, Guifen, Xia, Jie, Du, Guanhua, Yang, Xiuying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788431/ https://www.ncbi.nlm.nih.gov/pubmed/36557826 http://dx.doi.org/10.3390/molecules27248692

Ejemplares similares

Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
por: Yin, Lin, et al.
Publicado: (2022)

3D Pharmacophore-Based Virtual Screening and Docking Approaches toward the Discovery of Novel HPPD Inhibitors
por: Fu, Ying, et al.
Publicado: (2017)

Ligand-based pharmacophore modeling, virtual screening and biological evaluation to identify novel TGR5 agonists
por: Zhao, Shizhen, et al.
Publicado: (2021)

Discovery of YopE Inhibitors by Pharmacophore-Based Virtual Screening and Docking
por: Ozbuyukkaya, Gizem, et al.
Publicado: (2013)

Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies
por: Ghorayshian, Atefeh, et al.
Publicado: (2023)

Combining docking with pharmacophore filtering for improved virtual screening
por: Peach, Megan L, et al.
Publicado: (2009)

PharmDock: a pharmacophore-based docking program
por: Hu, Bingjie, et al.
Publicado: (2014)

Pharmacophore-Based Similarity Scoring for DOCK
por: Jiang, Lingling, et al.
Publicado: (2014)

Pharmacophore‐guided Virtual Screening to Identify New β(3)‐adrenergic Receptor Agonists
por: Ujiantari, Navista Sri Octa, et al.
Publicado: (2022)

Toll-Like Receptor 7 Agonists: Chemical Feature Based Pharmacophore Identification and Molecular Docking Studies
por: Yu, Hui, et al.
Publicado: (2013)

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
por: Jang, Cheongyun, et al.
Publicado: (2018)

Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands
por: Alamri, Mubarak A, et al.
Publicado: (2019)

Discovery of New Liver X Receptor Agonists by Pharmacophore Modeling and Shape-Based Virtual Screening
por: Temml, Veronika, et al.
Publicado: (2014)

Virtual screening using structure-based consensus pharmacophore models and ensemble docking based on MD-generated conformations
por: Koch, Oliver, et al.
Publicado: (2011)

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
por: Zhang, Yi, et al.
Publicado: (2020)

Identification of novel CDK2 inhibitors by a multistage virtual screening method based on SVM, pharmacophore and docking model
por: Liang, Jing-Wei, et al.
Publicado: (2019)

Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening
por: Guzelj, Samo, et al.
Publicado: (2022)

Structure Based Design, Synthesis, Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Novel Cyclophilin D Inhibitors
por: Valasani, Koteswara Rao, et al.
Publicado: (2014)

Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
por: Kaserer, Teresa, et al.
Publicado: (2015)

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors
por: Pal, Sourav, et al.
Publicado: (2019)

Pharmacophore-Based Virtual Screening of Novel Inhibitors and Docking Analysis for CYP51A from Penicillium italicum
por: Yuan, Yongze, et al.
Publicado: (2017)

Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors
por: Gaurav, Anand, et al.
Publicado: (2017)

Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores
por: Madzhidov, Timur I., et al.
Publicado: (2020)

Pharmacophore feature-based virtual screening for finding potent GSK-3 inhibitors using molecular docking and dynamics simulations
por: Chauhan, Navneet, et al.
Publicado: (2016)

Based on the Virtual Screening of Multiple Pharmacophores, Docking and Molecular Dynamics Simulation Approaches toward the Discovery of Novel HPPD Inhibitors
por: Fu, Ying, et al.
Publicado: (2020)

Pharmacophore modeling and virtual screening studies for discovery of novel farnesoid X receptor (FXR) agonists
por: Zhao, Shizhen, et al.
Publicado: (2021)

Search for the Pharmacophore of Histone Deacetylase Inhibitors Using Pharmacophore Query and Docking Study
por: Haji Agha Bozorgi, Atefeh, et al.
Publicado: (2014)

Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Discovery of Novel Akt2 Inhibitors
por: Fei, Jia, et al.
Publicado: (2013)

Pharmacophore-Aided Virtual Screening and Molecular Dynamics Simulation Identifies TrkB Agonists for Treatment of CDKL5-Deficiency Disorders
por: Ademuwagun, Ibitayo Abigail, et al.
Publicado: (2023)

In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches
por: Sahayarayan, Jesudass Joseph, et al.
Publicado: (2021)

Molecular docking, pharmacophore based virtual screening and molecular dynamics studies towards the identification of potential leads for the management of H. pylori
por: Damale, Manoj G., et al.
Publicado: (2019)

Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis
por: Ren, Ji-Xia, et al.
Publicado: (2020)

Generation of structure-based pharmacophores using energetic analysis – application on fragment docking
por: Loving, Kathryn, et al.
Publicado: (2011)

Pharmacophore Modeling and Docking Studies on Some Nonpeptide-Based Caspase-3 Inhibitors
por: Sharma, Simant, et al.
Publicado: (2013)

Integrative Ligand-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Simulation Approaches Identified Potential Lead Compounds against Pancreatic Cancer by Targeting FAK1
por: Molla, Mohammad Habibur Rahman, et al.
Publicado: (2023)

The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
por: Lu, Shin-Hua, et al.
Publicado: (2011)

3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Tubulin Inhibitors with Potential Anticancer Activity
por: Mirzaei, Salimeh, et al.
Publicado: (2021)

A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations
por: Susanti, Ni Made Pitri, et al.
Publicado: (2021)

Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations
por: Rafiq, Huma, et al.
Publicado: (2023)

Discovery of Novel Focal Adhesion Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approach Based on Multicomplex-Based Pharmacophore and Molecular Docking
por: Wu, Fengbo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0i7cefmvpv55bfit6ln6osgam2